glutathione down syndrome Nineteen-year follow-up of a patient with severe synthetase deficiency Ask the Doctors - What

de Ruijter TC, Veeck J, de Hoon JP, van Engeland M, Tjan-Heijnen VC

Composition GHK-Cu: 50 mg BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of copper peptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of three co-formulated peptides Stability characterization of a three-analyte lyophilized blend under laboratory storage conditions Method documentation for HPLC/LC-MS identity and purity assessments Documentation Analysis Report Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability

Powerful Detoxification 2

Clinical trials show an average weight loss of about 15% of body weight over 68 weeks